2026 · 3rd Quarter (July 1 - Sep 30)

NOVOZYMES NORTH AMERICA, INC.

Filed by NOVOZYMES NORTH AMERICA, INC..

Open official filing

Source-reported fields

Filing overview

Type: 3rd Quarter - Report
Posted: Oct 20, 2026
Income: Not reported
Expenses: $110,000.00
Registrant: NOVOZYMES NORTH AMERICA, INC.
Client: NOVOZYMES NORTH AMERICA, INC.
Filing UUID: b9dc526b-ad42-491a-96fc-ba552ad0391d
Termination date: Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

ENV · Environment/Superfund

Issues related to renewable fuels and expanded availability of E15, including education and advocacy concerning the biofuels industry.

AGR · Agriculture

Issues pertaining to nutrition and Generally Recognized as Safe (GRAS) requirements, including FDA regulation of food and feed ingredients, GRAS modernization, national uniformity; issues pertaining to biotechnology, including H.R. 2756, the National Biotechnology Initiative Act of 2025; and issues related to dietary supplements, including H.R. 7366, the Dietary Supplement Regulatory Uniformity Act.

Literal federal measure citations: H.R. 2756, H.R. 7366

TRA · Transportation

Issues pertaining to supply chain operations, movement of containers, SHIP IT Act (not yet introduced) related issues, and tariffs.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.